AtaiBeckley (ATAI) Liabilities and Shareholders Equity (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Liabilities and Shareholders Equity of $264.9 million for Q1 2026, down 9.51% quarter-over-quarter from $292.7 million in Q4 2025.
Analysis
AtaiBeckley (ATAI) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
AtaiBeckley's Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $264.9 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $264.9 million; the TTM figure through Mar 2026 stood at $717.0 million (changed N/A YoY), while the FY2025 annual figure was $292.7 million, up 83.66% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $264.9 million, down from $292.7 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $342.6 million in Q3 2022 and troughed at $885000.0 in Q1 2021.
- A 5-year average of $178.6 million and a median of $239.8 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
- Peak annual rise in Liabilities and Shareholders Equity reached 83.66% in 2025, while the deepest fall reached 83.66% in 2025.
- AtaiBeckley's Liabilities and Shareholders Equity stood at $159.4 million in 2024, then soared by 83.66% to $292.7 million in 2025, then decreased by 9.51% to $264.9 million in 2026.
- Business Quant data shows ATAI's Liabilities and Shareholders Equity at $264.9 million in Q1 2026, $292.7 million in Q4 2025, and $159.4 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 10.96 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.32 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9.18 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.10 Bn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | 239.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 264.79 Mn |
| Mar 31, 2026 | 264.88 Mn |
| Dec 31, 2025 | 292.72 Mn |
| Sep 30, 2025 | 239.82 Mn |
| Jun 30, 2025 | 189.20 Mn |
| Mar 31, 2025 | 195.78 Mn |
| Dec 31, 2024 | 159.39 Mn |
| Dec 31, 2024 | 159.39 Mn |
| Sep 30, 2024 | 197.52 Mn |
| Jun 30, 2024 | 215.78 Mn |
| Mar 31, 2024 | 269.12 Mn |
| Dec 31, 2023 | 293.48 Mn |
| Sep 30, 2023 | 308.22 Mn |
| Jun 30, 2023 | 253.60 Mn |
| Mar 31, 2023 | 280.72 Mn |
| Dec 31, 2022 | 305.44 Mn |
| Mar 31, 2022 | 383.73 Mn |
| Dec 31, 2021 | 4.76 Mn |
| Sep 30, 2021 | 885,000.00 |
| Jun 30, 2021 | 885,000.00 |